Top news of the week: 20.05.2021.
Startups
Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets in Asia
Drug licenser LianBio and recently IPO’d autoimmune biotech Landos Biopharma are joining forces to develop and sell two ulcerative colitis and Crohn’s disease assets in China and parts of ...
EureKARE raises $60M to create EU synbio and microbiome startups
EureKARE has raised a $60 million series A round to fund the creation and advancement of synthetic biology and microbiome startups. The cash will enable eureKARE to build companies around ...
What Data Reveals About Why Some Startups Reach Billion-Dollar Valuations
In his new book, <em>Super Founders</em>, venture capitalist Ali Tamaseb uses data to uncover why most conventional wisdom about startup success is wrong.
Biopharma R&D 'surged' in 2020, but trial productivity levels a mixed bag: report
A major global pandemic was not enough to stop surging rates of biopharma research and development, but trial productivity still remains below the long-term average.
Using machine learning to predict high-impact research
DELPHI, an artificial intelligence framework built by MIT Media Lab researchers, can give an “early-alert” signal for future high-impact technologies by learning from patterns gleaned from ...
INSIDE BIOTECH: See the drug companies that are growing the fastest and pay workers the most
Insider analyzed data from more than 150 biotech and pharmaceutical companies on headcount and compensation for workers and CEOs.
MassBio® Welcomes Two Members to its Board of Directors
The Massachusetts Biotechnology Council (MassBio®) today announced the appointment of two life sciences executives to the organization’s Board of Directors.
Biogen gene therapy misses goal in eye disease study
The results are a setback for Biogen, which spent $800 million two years ago to acquire the treatment's developer, Nightstar Therapeutics.